23
DAFTAR PUSTAKA
1. Francis GS, Gassler JP, Sonnenblick EH. 2005. Pathophysiology and diagnosis of Heart Failure. In: Fusler V, Alexander RW, O’Rourke RA (ed). The Heart 10th edition. vol 1:655-685
2. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. 2009. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with International Society for Heart and Lung Transplantation. J Am Coll Cardiol. Vol 119:393-475
3. Levy D, Kenchaiah, Larson MG, Benjamin EJ, Kupka MJ, Kalon KL et al.2002. Long terms Trends in the incidence and Survival with Heart Failure. N Engl J Med. Vol 347:1397-1402
4. Anand I, McMurray JJV, Whitmore J, Warren M, Pham A, McCamish MA et al. 2004. Anemia and its relationship in heart failure. Circulation. Vol 110: 149-154
5. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG et al.2006. Etiology of anemia in patients with advanced heart failure. Journal of the American college of cardiology.vol 48(12): 2486-2489
6. Jankowska EA, Rozentry P, Witkowska A,Nowak J, Hartmann O, Ponikowska B et al. 2010. Iron Deficiency: an aminous sign in patients with systolic chronic heart failure. European Heart Journal. vol Juni: 1-9 7. Tobili JE, Lombrana A, Duarte P, Gennaro FD.2007. Intravenous iron
reduced NT-pro-brain natriuretic peptide in anemia patients with chronic heart failure and renal insufficiency. J AM Coll Cardiol. vol 50:1657-1665 8. Okonko DO, Grzeslo A, Witkowski T. 2008. Effect of intravenous iron
sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol. vol 51: 103-112
9. Anker SD, Colet JC, Filippatos G.2009. Rationale and design of Ferinject assessment in patients with iron deficiency and chronic heart failure (FAIRHF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anemia. Eur J Heart Fail. Vol 11: 1084-1091
10.Klip IT, Comin-colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W et al. 2013. Iron deficiency in chronic heart failure: An international pooled analysis. American Heart Journal.vol 165 (4): 575-582
24
11.Rangel I, Goncalves A, de Sousa C, Leite S, Campelo M, Martins E et al.2014. Iron deficiency status irrespective of anemia: a predictor of unfavorable inchronic heart failure patients. Cardiology. vol 128: 320-326 12.Shah R, Agarwal AK. 2013. Anemia associated with chronic heart failure:
current concepts. Clinical Interventions in aging. vol 8:111-122
13.Alexandrakis MG, Tsirakis G.2012. Anemia in heart failure patients. ISRN Haematology.
14.Anand IS. Anemia and chronic heart failure. Journal of The American college of cardiology. 2008; 52(7): 501-511
15.Silverberg DS, Wexler D, Palazzuoli A. 2009. The anemia of heart failure. Acta haematologica. vol 122: 109-119
16.Jankowska EA, Haehling SV, Anker SD, MacDougall IC, Ponikowski P. 2013. Iron Defisiensi and Heart Failure: diagnostic dilemmas and therapeutic perspectives. European Heart Journal. vol 34: 816-826
17.Handelma GJ, Levin NW. 2008. Iron and anemia in human biology: a review of mechanisms. Heart Fail Rev.vol 13: 393-404
18.Hillman R, Ault KA, Rinder HM.2002. Hematology in clinical practice. Fourth edition. Mc Graw Hill. pp: 12-64
19.Okonko DO, Mandal AKJ, Missouris CG, Wilson PAP. 2011. Disordered iron homeostasis in chronic heart failure. Journal of American college of cardiology. vol58(12): 1241-1251
20.Opasich C, Cazzola M, Scelsi L,Feo SD, Bosimini E, Lagioia R et al. 2005.Blunted erythropoietin production and defective iron supply for erythropoiesis as major cause of anemia in patients with chronic heart failure. European heart journal. vol 26: 2232-2237
21.Tang YD, Katz SD.2006. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation. Vol 113:2454-61.
22.Wish JB. 2006. Assesing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. vol 1(Suppl):S4-S8
23.WHO. 2004. Assesing iron status of population, Report of a Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level Second edition.
24.Franchini M, Targher G, Montagnana M, Lippi G. 2005. Iron and thrombosis. Annals hematology. 87: 167-173
25.Dan K. 2005. Thrombocytosis iniron deficiency anemia. Intern Med. 44: 1025-1026
26.Karpatkin S, Garg S, Freedman M.1974. Role of Iron as a regulator of thrombopoiesis. Am J Med. 57: 521-525
27.Caramelo C, Just S, Gil P.2007. Anemia in heart failure: pathophysiology, pathogenesis, treatment and incognitae. Rev Esp Cardiol.60(8): 848-860
25
28.Dunlay SD, Weston SA, Redfield MM, Killian JM, Roger VL.2008. Anemia and heart failure: a community study. Am J Med. 121: 726-732 29.Koo HM, Kim CH, Doh FM, Lee MJ, Kim EJ, Han JH et al. 2014.The
Relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis. Plos ONE 9(2):e8721
